Hamostaseologie

Article	Citations
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	156
Factor XI as a Target for New Anticoagulants	58
Platelets and COVID-19	54
Platelet Shape Changes during Thrombus Formation: Role of Actin-Based Protrusions	29
Thrombophilia, Thrombosis and Thromboprophylaxis in Pregnancy: For What and in Whom?	26
Ovarian Vein Thrombosis: A Narrative Review	24
Procoagulant Platelets: Mechanisms of Generation and Action	22
Management of Disseminated Intravascular Coagulation in Acute Leukemias	18
Effects and Side Effects of Platelet Transfusion	14
A Review of FXIa Inhibition as a Novel Target for Anticoagulation	13
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH	13
Anti-inflammatory Strategies in Atherosclerosis	13
Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice	13
COVID-19 and Cardiac Arrhythmias	13
Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms	12
Pulmonary Hypertension and COVID-19	11
Management of Antithrombin Deficiency in Pregnancy	11
An Update on Laboratory Diagnostics in Haemophilia A and B	10
When and How to Combine Antiplatelet and Anticoagulant Drugs?	10
Bleeding Risk Assessment in Patients with Venous Thromboembolism	10
Cardiac and Cerebral Arterial Complications of Lemierre Syndrome: Results from a Systematic Review and Individual Patient Data Meta-analysis	10
Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces	9
COVID-19 and Myocarditis: Findings from Cardiac Magnetic Resonance Imaging and Endomyocardial Biopsies	9
Anticoagulation in Pediatric Patients	9
Platelets in Myocardial Ischemia/Reperfusion Injury	9

Functional Roles of the von Willebrand Factor Propeptide	9
Consensus Recommendations for Intramuscular COVID-19 Vaccination in Patients with Hemophilia	9
Molecular Profiling of Liver Sinusoidal Endothelial Cells in Comparison to Hepatocytes: Reflection on Which Cell Type Should Be the Target for Gene Therapy	8
New Developments in the Pathophysiology and Management of Primary Immune Thrombocytopenia	8
Fine-Tuning of Platelet Responses by Serine/Threonine Protein Kinases and Phosphatases—Just the Beginning	8
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)	7
Anticoagulation in Critically Ill Adults during Extracorporeal Circulation	7
Diagnosis of Platelet Function Disorders: A Challenge for Laboratories	7
Extended Half-Life Factor VIII/Factor IX Products: Assay Discrepancies and Implications for Hemophilia Management	7
COVID-19 and the Incidence of Acute Myocardial Injury	7
Emicizumab for All Pediatric Patients with Severe Hemophilia A	7
Platelets and Matrix Metalloproteinases: A Bidirectional Interaction with Multiple Pathophysiologic Implications	6
How the COVID-19 Pandemic Impacts Lives of Life Scientists	6
Interventional Treatment Options in Children with Extracranial Vascular Malformations	6
Venous Thrombosis and SARS-CoV-2	6
Microvascular Skin Manifestations Caused by COVID-19	6
Measuring Fibrinolysis	6
Venous Thromboembolism Issues in Women	6
Bleeding Issues in Women Under Oral Anticoagulation	5
Global Coagulation Testing in Acute Care Medicine: Back to Bedside?	5
The Concept of Thromboinflammation	5
Markers of Hereditary Thrombophilia with Unclear Significance	5
Thromboinflammation as a Driver of Venous Thromboembolism	5
Nonfactor Therapies: New Approaches to Prophylactic Treatment of Haemophilia	5
Anticoagulation Therapy in Cancer Patients with Thrombosis in the Outpatient Sector of Germany (The CERTIFICAT Initiative)—German Practice of Anticoagulation Therapy of Cancer Patients with Thrombosis	5
Treatment of Inherited Platelet Disorders: Current Status and Future Options	4
Analysis of an Inherited Dysfibrinogenemia Pedigree Associated with a Heterozygous Mutation in the FGA Gene	4
Celiac Artery Thrombosis and Splenic Infarction as a Consequence of Mild COVID-19 Infection: Report of an Unusual Case	4
Flow Cytometric Assessment of AKT Signaling in Platelet Activation: An Alternative Diagnostic Tool for Small Volumes of Blood	4
Screening for Cancer in Patients with Acute Venous Thromboembolic Disease	4
Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature	4
An Update on Safe Anticoagulation	4
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies	4
Pathogenic Aspects of Inherited Platelet Disorders	4
Do miRNAs Have a Role in Platelet Function Regulation?	4
Insights from the Hereditary Thrombotic Thrombocytopenic Purpura Registry: Discussion of Key Findings Based on Individual Cases from Switzerland	4
Thrombosis and Dissection of the Abdominal Arteries Associated with Infarcts of Solid Organs in a Patient with COVID-19: A Novel Clinical Entity	3
Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence	3
New Opportunities for Diagnosis and Prognosis of Stroke: The Benefits of Across Border Approaches	3
COVID-19: SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia	3
Cerebral Venous Thrombosis: What's New?	3
Low von Willebrand Disease: A Bleeding Disorder of Unknown Cause?	3
Transgender Medicine and Risk of Venous Thromboembolism	3
Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation	3
GTH 2021: simply online … worth experiencing	3
Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	3
The Current Evidence of Pulmonary Embolism Response Teams and Their Role in Future	3
Potentials of Endothelial Colony-Forming Cells: Applications in Hemostasis and Thrombosis Disorders, from Unveiling Disease Pathophysiology to Cell Therapy	3
100 Years of Thrombotic Thrombocytopenic Purpura: A Story of Death and Life	3
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal Haemoglobinuria	3

Osteoporosis Remains Constant in Patients with Hemophilia—Long-Term Course in Consideration of Comorbidities	3
Anticoagulation in Patients with Platelet Disorders	3
Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis	3
Inhibition of MicroRNA-122-5p Relieves Myocardial Ischemia-Reperfusion Injury via SOCS1	3
Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia	3
Cancer-Associated Venous Thromboembolism—Diagnostic and Therapeutic Considerations: An Update Based on the Revised AWMF S2k Guideline	3
A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy	3
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far	3
Novel Likely Pathogenic Variant in the A3 Domain of von Willebrand Factor Leading to a Collagen-Binding Defect	3
Flow Chamber Analyses in Cardiovascular Research: Impact of Platelets and the Intercellular Crosstalk with Endothelial Cells, Leukocytes, and Red Blood Cells	3
Communication in Healthcare: Global challenges in the 21st Century	3
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group	3
Preexisting Chronic Thromboembolic Pulmonary Hypertension in Acute Pulmonary Embolism? A Case Report and Discussion	3
Von Willebrand Disease—Specific Aspects in Women	2
Venous Thromboembolism in Women with Cancer with an Additional Focus on Breast and Gynecological Cancers	2
Direct Oral Anticoagulants for Pulmonary Embolism	2
Current Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms	2
Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype	2
Pathophysiology of Trauma-Induced Coagulopathy	2
GTH 2021: ACROSS BORDERS	2
State-of-the-Art Targeted High-Throughput Sequencing for Detecting Inherited Platelet Disorders	2
Diagnosing Inherited Platelet Disorders: Modalities and Consequences	2
Evidence-Based Medicine: Principles and Values as Illustrated by the Case of Patient Blood Management	2
The Use of Large Animal Models in Trauma and Bleeding Studies	2
Pitfalls in Coagulation Testing	2
Platelet Dysregulation in the Pathobiology of COVID-19	2
VTE Risk Assessment and Prevention in Pregnancy	2
New Anticoagulants in Neonates, Children, and Adolescents	2
GTH 2021: The First Online Experience! Useful for Future Meetings?	2
Acquired von Willebrand Syndrome in Children	2
Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion	1
Thrombocytopenia Absent Radius (TAR)-Syndrome: From Current Genetics to Patient Self-Empowerment	1
A Novel Homozygous Missense Mutation (Ile583Asn) in a Consanguineous Marriage Family with Hereditary Factor XII Deficiency: A Case Report	1
Cardio-Oncology: A New Discipline in Medicine and Its Relevance to Hematology	1
Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis	1
Rectus Sheath Hematoma in a Patient with Dual-Antiplatelet Therapy Including Ticagrelor: A Case Report	1
Expression and Release of Tumor Cell Tissue Factor Triggers Recurrent Thromboembolism in a Patient with Endometrial Cancer	1
Direct Oral Anticoagulants after Ischemic Stroke: Which Patient? Which Drug? And How Early?	1
Investigations on the Hemostatic Potential of Physiological Body Fluids	1
Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms	1
Non–Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease	1
Treatment of Atypical Clots	1
The Diagnostic Approach to Inherited Mild (to Moderate) Bleeding Disorders: A Current Perspective	1
COVID-19: Cardio-pulmonary and Vascular Manifestations	1
GTH 2021 State of the Art—Cardiac Surgery: The Perioperative Management of Heparin-Induced Thrombocytopenia in Cardiac Surgery	1
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	1
Reshaping Anticoagulation: Factor XI Inhibition in Thrombosis Management	1
Marker der Akute-Phase-Reaktion könnten Blutungen bei Hämophilie detektieren	1
Reference Intervals in Coagulation Analysis	1
Pulmonary Embolism: An Update Based on the Revised AWMF-S2k Guideline	1
Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma	1
High Prevalence of Plasminogen Activator Inhibitor-1 4G/5G Polymorphism among Patients with Venous Thromboembolism in Kerala, India	1
Management of Vascular Thrombosis in Patients with Thrombocytopenia	1
Immune Thrombocytopenia: Characteristics of the Population and Treatment Methods—One-Center Experience	1
Update on Tissue Factor Detection in Blood in 2024: A Narrative Review	1
Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause	1
Direct Oral Anticoagulants: Laboratory Challenges and Antidotes	1
Inherited Platelet Disorders: A Short Introduction	1
Laboratory Findings, Medical Imaging, and Clinical Outcome in Children with Cerebral Sinus Venous Thrombosis	1
Simply Online? Lessons from Virtual Scientific Conferences for the Post-COVID-19 Era	1
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria	1
Impact of Tyrosine Kinase Inhibitors Applied for First-Line Chronic Myeloid Leukemia Treatment on Platelet Function in Whole Blood of Healthy Volunteers In Vitro	1
Successful Secondary Endovascular Intervention in Pediatric Patients with Venous Thromboembolic Events	1
Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia	1
Acid Treatment of FVIII-Containing Plasma Samples Unmasks a Broad Spectrum of FVIII-Specific Antibodies in ELISA	1
Subsegmental Pulmonary Embolism	1
Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline	1
Thrombotic Thrombocytopenic Purpura: When Basic Science Meets Clinical Research	1
Novel Perspectives on Thrombopoietin Receptor Agonists Applications	1
Assessment of Factor VIII Activity and D-Dimer Levels in the Post-COVID Period	1
Intravital Imaging of Thrombosis Models in Mice	1
Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism	1
Spontaneous Intra-abdominal Hemorrhage in a Hemophilia A Patient Masquerading as Intra-abdominal Pseudotumor	1
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report	1
Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis	1
High Prevalence of F2 20210G > A in Splanchnic Vein Thrombosis and Cerebral Venous Sinus Thrombosis: A Retrospective Cohort Study of Patients with Thrombosis in Atypical Sites	1
	0
Programm für die Veranstaltung des BDDH im Rahmen der 68. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung in Wien 2024 und Petition an den Deutschen Bundestag aufgrund eines drohen	0
	0
	0

	0
	0
Hemostaseology in Pediatrics	0
Cardiovascular Risk Assessment in COVID-19	0
Facial Hematoma: An Atypical Bleeding Site for Acquired Hemophilia	0
A Vicious Circle of Clonal Haematopoiesis of Indeterminate Potential and Cardiovascular Disease	0
GTH News	0
COVID19 und Versorgung mit Blutkomponenten, aktueller Stand bzgl. Einführung der Telematik-Infrastruktur, GSAV und ASV	0
Chronic Venous Disease: Pathophysiological Aspects, Risk Factors, and Diagnosis	0
Nachruf auf Rainer B. Zotz und Ankündigung der BDDH-Veranstaltung auf der GTH in Frankfurt 2023	0
Gründung des Fachausschusses für das Deutsche Hämophilieregister (DHR) und Medizinische Informationsobjekte (MIO)	0
	0
	0
Residuale Venenokklusion nach längerer Antikoagulanzien-Therapie nicht mit erneuten venösen Thromboembolien assoziiert	0
Postthrombotisches Syndrom: SOX-PTS-Score und Méan-Modell zeigen beste Prädiktion	0
COVID-19: Kinetikmessung der thrombozytären ATP-Freisetzung prognostisch hilfreich	0
	0
Efgartigimod hilft bei Immunthrombozytopenie	0
Post–Pulmonary Embolism Syndrome: An Update Based on the Revised AWMF-S2k Guideline	0
Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice	0
iTTP in der Schwangerschaft: Erfolgreiche Behandlung mit Caplacizumab	0
	0
Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics	0
Rivaroxaban ist bei Malignom-assoziierten Thrombembolien nicht unterlegen	0
Geringe α-Thrombin/GPIbα-Interaktion trägt möglicherweise zur Hyperreaktivität der Thrombozyten bei COVID-19-Patienten bei	0
Thrombozytopenie: Sind Thrombozytentransfusionen vor Legen eines ZVK verzichtbar?	0
Use of Vonicog Alpha and Acquired von Willebrand Syndrome, a New Approach: A Case Report	0
Fachgespräche zur Plasma-Versorgung in Deutschland und Sachstand zur neuen Gebührenordnung für Ärzte (GOÄ)	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Runder Tisch zum deutschen Hämophilieregister (DHR), drohender Praxenkollaps, Stand und Zukunft der ambulanten hämostaseologischen Versorgung in Deutschland	0
Orale Antikoagulation mit VKA: Nicht-CYP2C9-inhibierende SSRI einsetzen!	0
Transfusion älterer Erythrozyten erhöht Mortalität und Thromboembolie-Risiko	0
GTH News	0
GTH News	0
Erratum: A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	0
GTH News	0
	0
Nachlese zur Veranstaltung des BDDH am 03.03.2022 im Rahmen der 66. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) in Leipzig	0
Probleme der Digitalisierung sowie Protest gegen das Finanzstabilisierungsgesetz	0
Editorial	0
Laboratory Testing: Current Aspects	0
Veranstaltung des Berufsverbandes im Rahmen des virtuellen GTH-Kongresses 2021, aktuelle Corona-Sonderreglungen und Reimport von Gerinnungsfaktoren	0
Association of Thrombin-Activatable Fibrinolysis Inhibitor with Acute Pulmonary Embolism	0
	0
A kaleidoscope of selected contributions to hemostasis and thrombosis – an introduction and some editorial remarks	0
Gentherapie in der Hämophilie A und B “Ante Portas”: Aktuelle Entwicklungen in der ärztlichen Vergütung und Bericht Tagung Ethikrat	0
GTH News	0
Erratum: Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	0
Tranexamsäure hemmt Fibrinolyse nach Kaiserschnitt	0
A Cross-sectional Analysis of Treatment in PUPs in 2021 in Germany – First Data from the GEPHARD Study Group	0
Medizinforschungsgesetz, Apothekenreform-Gesetz, Telemedizin Blutspende-Verordnung, Erweiterung der Dokumentationspflichten im Deutschen Hämophilieregister (DHR)	0
Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline	0
Die Gesellschaft für Thrombose- und Hämostaseforschung e.V. informiert	0
Aktueller Bericht der BDDH über die aktuellen gesundheitspolitischen Entwicklungen mit politischer Einordnung	0
Blutspende auch ohne Arztanwesenheit und aktueller Stand des Apothekenreform-Gesetzes (ApoRG)	0
Übergewicht und Adipositas erhöht Risiko für venöse Thromboembolien	0
Intensive Care Treatment of Pulmonary Embolism: An Update Based on the Revised AWMF S2k Guideline	0
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction	0
Pulmonary Embolism: Don't Start Me to Talkin'	0
A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia	0
GTH 2024: Building Bridges in Coagulation	0
	0
Evaluation der Vertriebswegänderung und der gesetzlichen Folgeänderungen für Gerinnungsfaktorenzubereitungen; Digitalisierung im Gesundheitswesen: Elektronische Patientenakte; Aktueller Stand bzgl. ne	0
Progress in Hemostasis (Part 1): Improved Management of Inherited Platelet Disorders: Reality or Illusion?	0
GTH News	0
Haemostaseological pearls	0
Nachtrag zur kritischen Diskussion über das Deutsche Hämophilieregister (DHR) anlässlich der GTH-Jahrestagung in Frankfurt 2023, aktuelle Informationen zur Gefährdung der Versorgung mit Blutplasmaprod	0
Clopidogrel reduziert Infarktrisiko	0
GTH 2022: Sustainable Collaboration	0
	0
	0
Petition „Vergütung für medizinische Leistungen – Verbesserung der Rahmenbedingungen für die ambulante Versorgung“, ATMP-QS-Richtlinie Hämophilie und aktueller Stand zur Digitalisierung im Gesundheits	0
GTH News	0
Theme Issue: “Critical Management Decisions in Hemostasis and Thrombosis”	0
Genetic Analysis of Hereditary Coagulation Factor V Deficiency in Two Chinese Families Caused by Compound Heterozygous Mutations	0
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues	0
GTH News	0
Erratum: Effect of DDAVP on Platelet Activation and Platelet-Derived Microparticle Generation	0
	0
	0
Animal and Cellular Models in Thrombosis and Hemostasis	0
GTH News	0
PAS: Die Rolle von Natriumcitrat bei längerer Kaltlagerung von Thrombozyten	0
Blutungsneigung bei Morbus Waldenström: Mögliche Ursachen und Diagnosemöglichkeiten	0
Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)	0
	0
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment	0
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) a	0
Komplementdysregulation als Biomarker für Post Covid	0
	0
Current Topics from the Revised German S2k Guideline on Diagnosis and Treatment of Venous Thromboembolism	0
Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis	0
GTH News	0
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives	0